Meta-analysis of the association of beta2-adrenergic receptor polymorphisms with asthma phenotypes

dc.contributor.authorContopoulos-Ioannidis, D. G.en
dc.contributor.authorManoli, E. N.en
dc.contributor.authorIoannidis, J. P.en
dc.date.accessioned2015-11-24T19:04:41Z
dc.date.available2015-11-24T19:04:41Z
dc.identifier.issn0091-6749-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/20088
dc.rightsDefault Licence-
dc.subjectAllelesen
dc.subjectAsthma/*geneticsen
dc.subjectCase-Control Studiesen
dc.subjectCohort Studiesen
dc.subjectGenetic Predisposition to Diseaseen
dc.subjectHomozygoteen
dc.subjectHumansen
dc.subjectOdds Ratioen
dc.subjectPolymorphism, Geneticen
dc.subjectReceptors, Adrenergic, beta-2/*geneticsen
dc.subjectRisk Factorsen
dc.titleMeta-analysis of the association of beta2-adrenergic receptor polymorphisms with asthma phenotypesen
heal.abstractBACKGROUND: Two common polymorphisms of the beta2-adrenergic receptor gene (Arg16Gly and Gln27Glu ) have been extensively studied for their possible association with asthma-related phenotypes, but the results of individual studies have been inconclusive. OBJECTIVE: We aimed to integrate quantitatively the available evidence on the association of the Arg16Gly and the Gln27Glu polymorphisms with asthma, nocturnal asthma, asthma severity, and bronchial hyperresponsiveness. METHODS: Meta-analysis of case-control and cohort studies using random effects models. RESULTS: A total of 28 studies were included in the meta-analysis. The summary estimates suggested that neither the Gly16 nor the Glu27 allele contributes to asthma susceptibility overall (odds ratio [OR], 1.01; 95% CI, 0.90-1.13; and OR, 0.95; 95% CI, 0.83-1.09, respectively) or to bronchial hyperresponsiveness (OR, 0.90; 95% CI, 0.77-1.05; and OR, 1.07; 95% CI, 0.94-1.22, respectively). There was a strong association of Gly16 with nocturnal asthma (OR, 2.20; 95% CI, 1.56-3.11) and a less strong association with severe or moderate rather than milder asthma (OR, 1.42; 95% CI, 1.04-1.94). No such effects were seen for the Glu27 allele (OR, 1.02; 95% CI, 0.74-1.40; and OR, 0.82; 95% CI, 0.59-1.14, respectively). Moreover, there was evidence that Gly16 homozygotes had a much higher risk for nocturnal asthma (OR, 5.15; 95% CI, 2.44-10.84) and asthma severity (OR, 2.84; 95% CI, 1.62-4.96) than the Arg16 homozygotes. CONCLUSION: The Gly16 allele of the beta2-adrenergic receptor gene predisposes to nocturnal asthma, and this may also explain the association with asthma severity. Neither polymorphism modulates the risk for bronchial hyperresponsiveness or mild asthma.en
heal.accesscampus-
heal.fullTextAvailabilityTRUE-
heal.identifier.primary10.1016/j.jaci.2004.12.1119-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/15867853-
heal.identifier.secondaryhttp://ac.els-cdn.com/S0091674905000114/1-s2.0-S0091674905000114-main.pdf?_tid=46205294f089b5a3d2f1c0c717f78d1d&acdnat=1333364338_4cb44f62b5a0260cb1fde943d0ba818e-
heal.journalNameJ Allergy Clin Immunolen
heal.journalTypepeer-reviewed-
heal.languageen-
heal.publicationDate2005-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.typejournalArticle-
heal.type.elΆρθρο Περιοδικούel
heal.type.enJournal articleen

Αρχεία

Φάκελος/Πακέτο αδειών

Προβολή: 1 - 1 of 1
Φόρτωση...
Μικρογραφία εικόνας
Ονομα:
license.txt
Μέγεθος:
1.74 KB
Μορφότυπο:
Item-specific license agreed upon to submission
Περιγραφή: